2003
DOI: 10.1245/aso.2003.12.009
|View full text |Cite
|
Sign up to set email alerts
|

Follow-Up Surveillance for Recurrence After Curative Gastric Cancer Surgery Lacks Survival Benefit

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
78
1
3

Year Published

2012
2012
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 90 publications
(86 citation statements)
references
References 9 publications
(7 reference statements)
4
78
1
3
Order By: Relevance
“…Detection of early recurrence may theoretically allow patients to receive palliative treatments such as chemotherapy, resulting in better outcomes. In the study by Kodera's group, detection of recurrent disease at an asymptomatic stage enabled a greater proportion of patients to be treated with chemotherapy (P = 0.076), possibly because performance status was better at the time of detection [8]. Clearly, biology is a dominant factor when assessing for recurrence in gastric cancer.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…Detection of early recurrence may theoretically allow patients to receive palliative treatments such as chemotherapy, resulting in better outcomes. In the study by Kodera's group, detection of recurrent disease at an asymptomatic stage enabled a greater proportion of patients to be treated with chemotherapy (P = 0.076), possibly because performance status was better at the time of detection [8]. Clearly, biology is a dominant factor when assessing for recurrence in gastric cancer.…”
Section: Discussionmentioning
confidence: 99%
“…All four studies [3,[6][7][8] reported a statistically significant improvement in postrecurrence survival for the asymptomatic groups. Overall survival (OS) was only reported by Kodera et al [8] and Tan et al [2].…”
Section: Surveillance Modalities (Appendix 3 Of the Esm)mentioning
confidence: 99%
See 2 more Smart Citations
“…Nevertheless, it remains unproven whether patients with asymptomatic recurrence have better survival outcomes than those with symptomatic recurrence. This is possibly because the previous studies analyzed peritoneal and nonperitoneal cases of recurrence together, despite the documented differences in treatment strategies and efficacies [10,11]. Indeed, nonperitoneal recurrence can be treated and potentially even cured by surgery if it is detected early enough, whereas chemotherapy is the only treatment option for peritoneal recurrence even if it is detected before symptom presentation [12].…”
Section: Introductionmentioning
confidence: 99%